Potential Biomarkers to Distinguish Type 1 Myocardial Infarction in Troponin-Elevated Diseases

Classifying myocardial infarction by subtype is crucial for appropriate patient management. Although troponin is currently the most commonly used biomarker, it is not a specific marker for myocardial infarction and cannot distinguish subtypes. Furthermore, previous studies have confirmed that protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Sohyen, Park, Sang-Hyun, Mun, Sora, Lee, Jiyeong, Kang, Hee-Gyoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179038/
https://www.ncbi.nlm.nih.gov/pubmed/37175804
http://dx.doi.org/10.3390/ijms24098097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179038/
https://www.ncbi.nlm.nih.gov/pubmed/37175804
http://dx.doi.org/10.3390/ijms24098097

Ejemplares similares